Wellington Management Group’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.3M Buy
5,410,568
+1,706,632
+46% +$3.33M ﹤0.01% 1364
2026
Q2
$7.74M Buy
3,703,936
+799,025
+28% +$1.57M ﹤0.01% 1359
2026
Q1
$5.08M Buy
+2,904,911
New +$5.28M ﹤0.01% 1402

Other funds holding PALI

Wellington Management Group's PALI Position: Q3 2026 in Review

Wellington Management Group increased its Palisade Bio (PALI) stake by 46% in Q3 2026, buying an estimated $3.33M and bringing the position to 5,410,568 shares worth $7.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1364.

Wellington Management Group first reported a position in PALI in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.74M in Q2 2026. 116 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Wellington Management Group held 5,410,568 shares of Palisade Bio worth $7.3M as of Q3 2026.
  • Wellington Management Group bought 1,706,632 Palisade Bio shares in Q3 2026, an estimated $3.33M.
  • Palisade Bio made up ﹤0.01% of Wellington Management Group's portfolio in Q3 2026, its #1364 holding.
  • Wellington Management Group first reported a position in Palisade Bio in Q1 2026 and has held it in 3 quarters since.
  • Wellington Management Group's Palisade Bio position peaked at $7.74M in Q2 2026.
  • 116 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Wellington Management Group's 13F filing for Q3 2026, filed 16 Nov 2026.